Login / Signup

β-Cell Function, Incretin Effect, and Glucose Kinetics in Response to a Mixed Meal in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin.

Giuseppe DanieleAndrea TuraAlex BrocchiAlessandro SabaBeatrice CampiVeronica Sancho-BornezAngela DardanoStephano Del Prato
Published in: Diabetes care (2024)
SAXA+DAPA provided superior glycemic control compared with DAPA or SAXA, with improved β-cell function, insulin sensitivity, GLP-1 availability, and glucose clearance.
Keyphrases
  • glycemic control
  • blood glucose
  • type diabetes
  • weight loss
  • insulin resistance
  • blood pressure
  • metabolic syndrome